Insights into the Human Glycan Receptor Conformation of 1918 Pandemic Hemagglutinin–Glycan Complexes Derived from Nuclear Magnetic Resonance and Molecular Dynamics Studies by Elli, Stefano et al.
Insights into the Human Glycan Receptor Conformation of 1918
Pandemic Hemagglutinin−Glycan Complexes Derived from Nuclear
Magnetic Resonance and Molecular Dynamics Studies
Stefano Elli,† Eleonora Macchi,† Timothy R. Rudd,‡ Rahul Raman,§ Guillherme Sassaki,⊥
Karthik Viswanathan,§ Edwin A. Yates,∥ Zachary Shriver,§ Annamaria Naggi,† Giangiacomo Torri,†
Ram Sasisekharan,*,§ and Marco Guerrini*,†
†Istituto di Ricerche Chimiche e Biochimiche “G. Ronzoni”, Via Giuseppe Colombo 81, 20133 Milano, Italy
‡Diamond Light Source Ltd., Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0DE, U.K.
§Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77
Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
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ABSTRACT: The glycan receptor binding and speciﬁcity of
inﬂuenza A viral hemagglutinin (HA) are critical for virus
infection and transmission in humans. However, ambiguities in
the interpretation of the receptor binding speciﬁcity of
hemagglutinin from human- and avian-adapted viruses have
prevented an understanding of its relationship with aerosol
transmissibility, an exclusive property of human-adapted
viruses. A previous conformational study, which we performed,
indicated that human and avian receptors sample distinct
conformations in solution. On the basis of detailed nuclear
magnetic resonance (NMR) studies provided herein, we oﬀer
evidence of the distinct structural constraints imposed by
hemagglutinin receptor binding sites on the glycan conformational space upon binding. The hemagglutinin from the SC18 virus,
which has eﬃcient aerosol transmissibility in humans (human-adapted), imposed the most stringent constraints on the
conformational space of the human glycan receptor (LSTc), compared to single (NY18) or double (AV18) amino acid HA
mutants, a property correlating to the ligand−HA binding strength. This relationship was also observed for the avian-adapted
HA, where the high aﬃnity binding partner, AV18, imposed the most stringent conformational constraints on the avian receptor,
compared to those imposed by NY18. In particular, it is interesting to observe how diﬀerent HAs when binding to human or
avian glycosidic receptors impose signiﬁcantly diﬀerent conformational states, in terms of the states sampled by the glycosidic
backbone and/or the entire molecule shape (linear or bent), when compared to the corresponding unbound glycans.
Signiﬁcantly, we delineate a “characteristic NMR signature” for the human adapted hemagglutinin (SC18) binding to human
glycan receptors. Therefore, the conformational space constraints imposed by the hemagglutinin receptor binding site provide a
characteristic signature that could be a useful tool for the surveillance of human adaptation of other (such as H7N9 and H5N1)
deadly inﬂuenza viruses.
Inﬂuenza A viruses are among the most rapidly evolvingpathogens with potential for new strains to adapt to human
hosts and lead to a pandemic outbreak, with signiﬁcant
economic and public health impact.1,2 The emergence of novel
inﬂuenza strains such as 2009 H1N1 and 2010 H3N2 through
genetic reassortment3−5 poses a constant threat in terms of the
evolution of various subtypes, including H5N1, H7N2, H7N7,
H7N9, and H9N2, to generate a pandemic strain. The H5 and
H7 subtypes, among others, are categorized as avian-adapted
because they primarily circulate within birds, but through
contact with infected animals, they can jump species and infect
humans. Some of these avian-adapted viruses, including H5N1
and H7N9, upon infection, can replicate eﬃciently in various
human organs and lead to severe infection and mortality.6−11
However, these avian-adapted subtypes are not capable of
eﬃcient human-to-human aerosol transmission,12,13 a charac-
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teristic feature of subtypes such as H1N1, H2N2, and H3N2,
which are considered human-adapted.
A key factor governing human adaptation of the inﬂuenza A
virus is the binding speciﬁcity of viral surface glycoprotein
hemagglutinin (HA) to sialylated glycan receptors on the host
cell surface [glycans terminated by α-D-N-acetylneuraminic acid
(Neu5Ac)]. A canonical deﬁnition of this binding speciﬁcity
based on the terminal sialic acid linkage has been used in the
ﬁeld in recent decades. HA from avian-adapted subtypes such
as H5, H7, and H9 is known to bind speciﬁcally to glycans
terminated by α(2→3)-linked sialic acid [α(2→3) glycans or
avian receptors].14,15 Meanwhile, HA from human-adapted
subtypes such as H1, H2, and H3 is known to bind speciﬁcally
to glycans terminated by α(2→6)-linked sialic acid.16,17 This
deﬁnition based on sialic acid linkage alone, while useful for
characterizing many inﬂuenza strains, has misclassiﬁed some
notable strains in terms of their ability to eﬀect eﬃcient human-
to-human respiratory droplet transmission,18−20 in particular
H5N1 and H7N9.
Glycan receptors have been deﬁned according to their overall
conformation, via a parameter called the θ angle, which deﬁnes
the form of the nonreducing end of the glycan receptors
(Figure 1).18 Speciﬁcally, in the case of inﬂuenza, we previously
demonstrated that the apical surface of human upper
respiratory epithelia, which is a primary target for human-
adapted viruses, predominantly expresses glycan receptors with
long oligosaccharide branches terminated by α(2→6)-linked
sialic acid [α(2→6) glycan or human receptors].18,21 On the
basis of analyses of glycan conformation and topology in HA−
glycan X-ray cocrystal structures, we noted that the α(2→6)
glycans adopted an “umbrella-like” topology (θ angle of <100°)
in the receptor binding site (RBS) of H1 and H2 HAs, while
α(2→6) and α(2→3) glycans adopted “cone-like” topologies
(θ angle of >100°) in the RBS of H5 HA.18 This topology-
based deﬁnition, in addition to the speciﬁc sialic acid linkage
[i.e., α(2→3) vs α(2→6)], distinguished HA from human-
adapted subtypes binding to human receptors from the HA of
avian-adapted viruses binding to avian and human receptors.22
The relationship between the glycan receptor speciﬁcity of
HA and the aerosol transmissibility of the virus in ferrets (a
well-established animal model for respiratory droplet trans-
mission) was ﬁrst demonstrated using the prototypic 1918
H1N1 pandemic HA (A/South Carolina/1/18 or SC18).23
While SC18 showed eﬃcient aerosol transmission in ferrets, a
single amino acid mutation in HA (Asp225 → Gly; numbering
based on H3 HA) resulted in a virus, NY18, that exhibited
ineﬃcient transmission, and a second further mutation, Asp190
→ Glu, resulted in a virus, AV18, that could not be transmitted.
We previously demonstrated that SC18 HA bound with high
speciﬁcity and high aﬃnity to human receptors, while AV18 HA
bound with high aﬃnity to avian receptors. NY18 bound to
both avian and human receptors with a binding aﬃnity
substantially lower than that observed for AV18 and SC18.
Despite dramatic diﬀerences in the aerosol transmissibility of
these three viruses and their glycan receptor binding properties,
they showed similar infectivity, replication eﬃciency, and tissue
distribution in ferrets directly inoculated with virus. More
recently, this approach was extended to the 2009 H1N1 system,
revealing that the receptor speciﬁcity aﬀects neither replication
nor virulence of this pandemic virus in mice or ferrets, again
after intranasal inoculation, but did aﬀect animal-to-animal
transmission by respiratory droplets.24 These studies highlight
the signiﬁcance of HA mutations and glycan receptor binding
speciﬁcity (given that all other genes among the three viruses
are intact) in distinguishing aerosol transmissibility from other
phenotypic properties of the virus such as infectivity and
replication eﬃciency.
The dramatic changes in relative glycan receptor binding
aﬃnities and aerosol transmissibility resulting from single-
amino acid changes to SC18 prompted an investigation into the
structural nuances governing HA−glycan interactions. While
HA−glycan X-ray cocrystal structures revealed diﬀerences in
overall glycan topology (cone-like vs umbrella-like), when
bound to diﬀerent HAs, these “static” structures did not entirely
capture the restrictions imposed on the conformational space of
the glycan receptor by the RBS of diﬀerent HAs, in moving
from the free to HA-bound state.
For what is, to the best of our knowledge the ﬁrst time, we
present solution structures of LSTc [human receptor, Neu5Ac-
α(2→6)-Gal-β(1→4)-GlcNAc-β(1→3)-Gal-β(1→4)-Glc] and
LSTa [avian receptor, Neu5Ac-α(2→3)-Gal-β(1→3)-GlcNAc-
β(1→3)-Gal-β(1→4)-Glc] bound to SC18, NY18, and AV18
HAs, based on comprehensive nuclear magnetic resonance
(NMR) [saturation transfer diﬀerence spectroscopy (STD) and
transferred nuclear Overhauser eﬀect spectroscopy (tr-
NOESY)] analyses and molecular dynamics (MD) simulations.
The combination of both NMR and molecular dynamic
simulations is particularly powerful when investigating
protein−carbohydrate interactions, speciﬁcally when dealing
with the highly mobile carbohydrate ligand.25 We ﬁnd that
Figure 1. Schematic of LSTc (top) and LSTa (bottom). The θ angle
parameter is deﬁned by the angle across anomeric carbons of the three
successive residues starting from the nonreducing end (Neu5Ac, Gal-1,
and GlcNAc).
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these “dynamic” structures are instrumental in delineating the
conformational features of glycans when they are bound to HA.
Our study captures the active changes in conformation, θ angle,
and glycosidic linkage torsional angles of LSTa and LSTc
induced upon binding to HA and sheds light on distinct
structural constraints imposed by the RBS that diﬀer by one or
two amino acids. We report the new ﬁnding of deﬁning the
restriction on the glycan conformational space and mobility of
glycan bound to HA that, importantly, is not captured in the
corresponding “snapshot” cocrystal structures. Importantly,
these data are consistent with the observed diﬀerences in the
biochemical binding aﬃnities of these glycans for SC18, NY18,
and AV18 HAs. We discuss the implications of these ﬁndings
for our understanding of binding of HA to human receptors,
speciﬁcally the signiﬁcance of glycan conformation, θ angle, and
glycosidic torsional angles, and HA RBS interactions in
determining the appropriate speciﬁcity and aﬃnity. Our
ﬁndings will greatly aid future studies aimed at delineating
appropriate structural constraints on glycan topologies for other
inﬂuenza subtypes (such as H5N1 and H7N9), including
surveillance of adaption to humans by these deadly viruses.
■ MATERIALS AND METHODS
Cloning, Baculovirus Synthesis, Expression, and
Puriﬁcation of HA. The soluble form of HA was expressed
using the Baculovirus Expression Vector System (BEVS). SC18
(A/South Carolina/1/1918) baculovirus (generated from the
pAcGP67-SC18-HA plasmid26,27) was a gift from J. Stevens.
pAcGp67-NY18-HA and pAcGp67-AV18-HA plasmids were
generated from pAcGP67-SC18-HA by Asp225 → Gly and
Asp190 → Glu/Asp225 → Gly mutations, respectively.
Mutagenesis was conducted using the QuikChange Multi
Site-Directed Mutagenesis Kit (Stratagene). The primers used
for mutagenesis were designed using the web-based program
PrimerX (http://bioinformatics.org/primerx/) and synthesized
by IDT DNA technologies (Coralville, IA). NY18 and AV18
baculoviruses were created from pAcGP67-NY18-HA and
pAcGP67-AV18-HA constructs using a Baculogold system
(BD Biosciences, San Jose, CA) according to the manufac-
turer’s instructions. The baculoviruses were used to infect 300
mL suspension cultures of Sf9 cells (BD Biosciences) cultured
in BD BaculoGold Max-XP Insect Cell medium (BD
Biosciences). These cultures were monitored for signs of
infection and harvested 4−5 days postinfection. BEVS produces
trimeric HA that provides multivalent binding to glycans. The
soluble form of HA was puriﬁed from the supernatant of
infected cells using the protocol described previously.27 Brieﬂy,
the supernatant was concentrated using Centricon Plus-70
centrifugal ﬁlters (Millipore, Billerica, MA), and the trimeric
HA was recovered from the concentrated cell supernatant using
aﬃnity chromatography with columns packed with Ni-NTA
beads (Qiagen, Valencia, CA). Eluting fractions that contained
HA were pooled and dialyzed overnight with 10 mM Tris-HCl,
50 mM NaCl buﬀer (pH 8.0). Ion exchange chromatography
was then performed on the dialyzed samples using a Mono-Q
HR10/10 column (GE healthcare, Piscataway, NJ). The
fractions containing HA were pooled together and subjected
to ultraﬁltration using Amicon Ultra 100 K NMWL membrane
ﬁlters (Millipore). The protein was then concentrated and
reconstituted in PBS. The puriﬁed protein was quantiﬁed using
Bio-Rad’s protein assay (Bio-Rad, Hercules, CA).
NMR Analysis of SC18, NY18, and AV18 with LSTc and
LSTa. STD and tr-NOESY samples were prepared by washing
the proteins SC18, NY18, and AV18 (1 mg/mL) with a
buﬀered solution [150 mM sodium chloride, 100 mM sodium
phosphate, 0.3 mM d-EDTA, and D2O (pH 7.2)] using
Amicon Ultra centrifugal ﬁlters, and a 10 kDa membrane
(Millipore). Each ligand (LSTc or LSTa) was added to the
corresponding protein sample, yielding ﬁnal molar ratios of
100:1 (glycan receptor:HA) for the STD measurements and
25:1 (glycan receptor:HA) for the tr-NOESY measurements,
and the protein concentration for the STD measurements was
0.01 mM and for the tr-NOESY experiments was 0.04 mM.
NMR spectra were acquired using a Bruker 600 and 900 MHz
AVANCE series NMR spectrometer, both equipped with a
high-sensitivity 5 mm TCI cryoprobe. LSTc and LSTa
resonances were previously assigned.28 For the STD experi-
ments, the on-resonance frequency was set at 7.3 ppm (6600
Hz) and the oﬀ-resonance frequency at 20.0 ppm (18000 Hz),
a train of 40 Gaussian-shaped pulses of 50 ms each were applied
to produce a selective saturation of 2 s, and D1 was 6 s. The
number of scans was 1K, and the spectral width was 12626 Hz.
The two-dimensional NOESY experiments were conducted
using a mixing time of 300 ms; the data were recorded for
quadrature detection in the indirect dimension and acquired
using 16 scans per series of 2048 × 416 data points. The spectra
were recorded at 295 K.
Dose-Dependent Direct Binding of SC18, NY18, and
AV18 to Glycan Receptors LSTa and LSTc. LS-
tetrasaccharide c [LSTc, Neu5Ac-α(2→6)-Gal-β(1→4)-
GlcNAc-β(1→3)-Gal-β(1→4)-Glc)] and LS-tetrasaccharide a
[LSTa, Neu5Ac-α(2→3)-Gal-β(1→3)-GlcNAc-β(1→3)-Gal-
β(1→4)-Glc] (Accurate Chemicals) were biotinylated with
EZ-Link Biotin-LC-Hydrazide (Thermo) according to the
manufacturer’s instructions. Streptavidin-coated High Binding
Capacity 384-well plates (Pierce) were loaded to the full
capacity of each well by incubating the well with 50 μL of 2.4
μM biotinylated LSTa or LSTc overnight at 4 °C. Excess
glycans were removed through extensive washing with PBS.
The trimeric HA unit comprises three HA monomers, and the
spatial arrangement of the biotinylated glycans in the wells of
the streptavidin plate array favors binding to only one of the
three HA monomers in the trimeric HA unit. To speciﬁcally
enhance the correct multivalency in the HA−glycan inter-
actions, the recombinant HA proteins were precomplexed with
the primary and secondary antibodies in a molar ratio of 4:2:1
(HA:primary:secondary). The identical arrangement of four
trimeric HA units in the precomplex for all the HAs permitted
comparison between their glycan binding aﬃnities. A stock
solution containing appropriate amounts of histidine-tagged
HA protein, primary antibody (mouse anti-six-His tag IgG),
and secondary antibody (HRP-conjugated goat anti-mouse
IgG) (Santa Cruz Biotechnology, Santa Cruz, CA) was
combined in a ratio 4:2:1 and incubated on ice for 20 min.
Appropriate amounts of precomplexed stock HA were diluted
to 250 μL with 1% BSA in PBS; 50 μL of this precomplexed
HA was added to each of the glycan-coated wells and incubated
at room temperature for 2 h followed by the wash steps
described above. The binding signal was determined on the
basis of HRP activity using the Amplex Red Peroxidase Assay
(Invitrogen, CA) according to the manufacturer’s instructions.
The experiments were conducted in triplicate. Minimal binding
signals were observed in the negative controls, including
binding of the precomplexed unit to wells without glycans and
binding of the antibodies alone to the wells with glycans. The
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data obtained from this analysis can be found in Figure 1 of the
Supporting Information.
Molecular Dynamics Simulations. The dynamic and
conformational properties of the interaction between LSTc and
HA were studied by comparing the MD simulation trajectories
of three complexes: LSTc−SC18, LSTc−NY18, and LSTc−
AV18. The X-ray cocrystal structures of SC18 and NY18 were
recently determined with LSTa and LSTc.29 However, during
the preparation of this paper, the available cocrystal structures
were those of SC18 with LSTc [Protein Data Bank (PDB)
entry 2WRG], a swine H1N1 HA (A/swine/Iowa/30) with
LSTa and LSTc, and another human H1N1 (A/Puerto Rico/8/
34, PDB entry 1RVX30) with LSTa. These X-ray cocrystal
structures constituted reasonable starting models of HA−glycan
complexes for MD simulations. The LSTc−SC18 complex was
built starting with LSTc cocrystallized with SC18 HA [PDB
entry 2WRG; coordinates were available for tetrasaccharide
Neu5Ac-α(2→6)-Gal-β(1→4)-GlcNAc-β(1→3)-Gal-].31 The
protein, HA portion, of the complex was taken directly from
the PDB coordinates, selecting a sequence of 60−260 amino
acids (2WRG numbering) that includes the HA RBS. The
solution conformation of LSTc, determined previously,28 was
superposed onto the cocrystallized glycan structure, with the
nonreducing residues Neu5Ac and Gal-1 giving a root-mean-
square deviation (rmsd) of 6.5 Å. The remaining complexes
were obtained from the previously built LSTc−SC18 complex
by applying the single mutation Asp225 → Gly in silico to
generate the LSTc−NY18 complex and the double mutation
Asp225 → Gly/Asp190 → Glu to generate the LSTc−AV18
complex. It is important to note that at the start of the MD
simulation, the three complexes are characterized by exactly the
same conformation of LSTc and HA with the exception of
mutated residues.
The LSTa−AV18 complex was built by superimposing a
previously selected conformation of LSTa28 on the LSTa-like
trisaccharides cocrystallized with H1 (A/Puerto Rico/8/34
H1N1) with amino acids within the binding site typical of an
avian HA (PDB entry 1RVX). The rmsd between the
superposed glycans is 6.2 Å, calculated on residues Neu5Ac
and Gal-1. The previously built AV18 protein was superposed
on the HA in PDB entry 1RVX, matching the protein Cα
backbone (rmsd = 0.38 Å); then the complex was built by
taking LSTa and AV18. The LSTa−NY18 complex was built
from the latter complex (LSTa−AV18) by substituting Glu190
with Asp. Even in that case, the LSTa−AV18 and LSTa−NY18
model complexes have the same geometry at the beginning of
the MD simulations.
Ambertools 1.4 was used to build the force ﬁeld.
GLYCAM06/Amber was used to describe the glycan and
protein part of the complexes. The simulation cell was built by
enveloping each macromolecule by a water layer (TIP3P water
model) 15 Å wide in three directions, resulting in an
orthogonal cell with an edge of approximately 100 Å. The
nonbonded potential energy was described using the standard
cutoﬀ (12 Å) technique for both electrostatic and dispersive
interactions. Each cell was minimized using 100 K steps of the
default minimization algorithm included in NAMD. Then 1 ns
of MD simulation sampling the NPT ensemble was used to
equilibrate the cell density. The simulation temperature was set
at 295 K and maintained by a Langevin thermostat as
implemented in NAMD, while the Nose-́Hoover Langevin
piston algorithm controlled the pressure (1.01325 bar) applied
to the cell walls. During the minimization and cell density
equilibration steps, a harmonic potential energy restraint
(harmonic constant of 50 kcal mol−1) on all the atoms of the
complex was applied, while the water molecules were allowed
to move freely. The MD simulation for all the modeled
complexes was ∼120 ns and was completed by applying a soft
harmonic restraint on the HA backbone atoms (Cα, N, and
carbonyl carbon) with a harmonic constant of 2.0 kcal mol−1.
This allows the ligand and the side chain residues to be
adjusted, while the secondary structure elements are main-
tained. The MD simulation trajectory was sampled every 10 ps,
and the comparisons between the diﬀerent complexes were
conducted by monitoring selected distances between the ligand
and the HA active site residues (Figure 4).
MD Simulation Trajectory Principal Component
Analysis (PCA). PCA has been a powerful tool for the analysis
of protein32,33 and glycan28,34 molecular dynamics. Although in
these examples the PCA was used with the aim of extracting
distinct and independent motional modes, it has been used in
our study to identify the ﬁnal bound states in the LSTx−HA
complexes. Each frame of the glycan−HA MD trajectories was
converted from Cartesian coordinates to a distance matrix,
measured between the glycan and protein. The distances were
determined between the non-carbon and hydrogen atoms of
the glycan (excluding the glycosidic linkage oxygens and
including the carbon of the N-acetyl groups) and the amino
acid side chains of HA, the last carbon in the amino acid side
chain. A 6 Å cutoﬀ was applied to the distance matrices; this
means that only glycan−HA interactions were observed and
not the glycan rearranging in solution, away from the RBS.
These matrices were then converted into a vector, and all of
them, for a single MD trajectory, were placed into a matrix; this
data set was then mean-centered before principal component
analysis could be performed. Density-based cluster analysis was
performed on the ﬁrst two component loadings (the most
signiﬁcant); the time each cluster appeared in the MD
trajectory could then be compared. The ﬁrst 20 ns of each
trajectory was discarded; this left the time interval from 20 to
120 ns to be investigated, which was decomposed into 10000
distance matrices that were examined by PCA. This approach
allows the evolution of the glycan−HA complex to be observed,
from the initial state to the ﬁnal state. For the ﬁnal bound
states, the ϕ, ψ, and θ angles were determined as well as the
average glycan−protein contacts for that subset of conformers.
The glycan−protein contacts are represented as networks, with
the edge thickness being inversely proportional to distance (the
thicker the edge, the closer the vertices are); these can be found
in Figure 5 and Figures 8−11 of the Supporting Information.
Parameters That Deﬁne the Glycan Conformation and
Topology. The torsional angles (ϕ and ψ) are deﬁned as the
following pairs of dihedral angles: ϕ1 and ψ1, ϕ2 and ψ2, ϕ3 and
ψ3, and ϕ4 and ψ4 (starting from the nonreducing termini). For
LSTa, the ﬁrst pair is deﬁned as C1−C2−O3−C3 (ϕ1) and
C2−O3−C3−H3 (ψ1), while for LSTc, ϕ1 is the C1−C2−
O6−C6 angle and ψ1 the C2−O6−C6−C5 angle, as previously
deﬁned by Xu et al.35 Thereafter, successive pairs are deﬁned as
H1−C1−O4′−C4′ (ϕi) and C1−O4′-C4′−H4′ (ψi) for the
1→4 linkage or H1−C1−O3′−C3′ (ϕi) and C1−O3′−C3′−
H3′ (ψi) for the 1→3 linkage. Atoms labeled with a prime
belong to the monosaccharide on the reducing side of the
glycosidic linkage, while atoms without a prime are on the
nonreducing side of the glycosidic linkage. To be consistent
with Chandrasekaran et al.,18 Xu et al.,35 and Sassaki et al.,28
torsional angles ϕ and ψ were illustrated in the range of −120°
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to 240°. The torsional angles for the LSTc−HA and LSTa−HA
complexes are listed in Tables 1 and 2, respectively. The angles
were determined by cluster analysis of the data illustrated in
Figures 13 and 14 of the Supporting Information, and the
analysis used nonparametric density estimation36 to determine
the members of each cluster. The angles represented in the
tables are the average values for each ϕ and ψ cluster.
The topology of LSTa and LSTc is deﬁned using a θ angle
parameter. The θ angle is deﬁned by the C2, C1, and C1 atoms
of residues Neu5Ac, Gal, and GlcNAc (N-acetylglucosamine),
going from the nonreducing end to the reducing end (Figure
1).
■ RESULTS
NMR Structural Analyses of HA−Glycan Interactions.
NMR analyses were performed using a 900 MHz spectrometer,
which permitted unprecedented resolution for observation of
HA−glycan interactions. NMR STD experiments were
employed to obtain a qualitative description of the glycan
residues that interact with HA. NMR analysis indicated that for
both LSTa and LSTc (Figure 1) in complex with the diﬀerent
HAs, the main sugar residue involved in the contact is the
terminal sialic acid (Neu5Ac). However, there are diﬀerences in
the mode of binding for these glycans to the various HAs.
To aid the assignment of the one-dimensional STD signals,
spectra of LSTc bound to SC18 and NY18 were superimposed
on the HSQC spectrum of LSTc (Figures 2A and 3A). While
the interaction between LSTc and SC18 occurs primarily
through the nonreducing end Neu5Ac moiety, involving
protons H3ax, H3eq, H4, H5, H7, and H9 (Figure 2A), signals
belonging to Gal-1 (H6), GlcNAc (methyl group), Gal-2 (H4
and H1), and Glc (H5 and H6) are also present in the STD
spectrum (Figure 2A). Similarly, LSTc interacts with NY18
principally through Neu5Ac, (H4, H5, H7, and H9), whereas
signals belonging to Gal-2 and Glc appear to be absent or, at
best, weaker than those found in the STD spectrum of the
LSTc−SC18 complex. Notably, both methyl groups of GlcNAc
and Neu5Ac still interact with NY18, but these signals are
weaker than those observed in the LSTc−SC18 complex
(Figure 3A).
The greater number of proton signals corresponding to the
monosaccharides of LSTc that interact with SC18 compared to
NY18 is consistent with the dose-dependent direct biochemical
binding of these HAs to this glycan in an array platform (Figure
1 of the Supporting Information) and also with previously
reported human receptor aﬃnity of SC18 HA that is higher
than that of NY18 HA.20 The absence of STD signals observed
for the LSTc−AV18 complex (Figure 3 of the Supporting
Information) indicates that LSTc does not interact with AV18,
consistent with minimal to no binding of AV18 to LSTc that is
observed in the dose-dependent binding assay (Figure 1 of the
Supporting Information).
The avian receptor, LSTa, on the other hand, interacts with
AV18 and NY18 almost exclusively through Neu5Ac (Figure
2B). Because of the overlapping signals of the methyl groups
belonging to Neu5Ac and GlcNAc, it was not possible to
establish deﬁnitively which group interacts with the corre-
sponding HA (Figure 3B). Among the few STD signals that
Table 1. Glycosidic Torsional Angles for LSTc, Free and Bound to SC18, NY18, and AV18a
linkage cluster size percentage ϕ (deg) standard deviation (SD) of ϕ (deg) ψ (deg) SD of ψ (deg)
LSTc 1 1 9858 98.6 −57 11 190 17
2 48 0.5 −71 12 −114 5
3 73 0.7 −60 9 111 13
2 1 5430 54.3 42 11 −3 11
2 2419 24.2 −38 13 −29 11
3 2151 21.5 24 13 −32 10
3 1 4691 46.9 20 14 −47 13
2 3981 39.8 39 15 34 18
3 1328 13.3 −25 11 −43 11
4 1 5934 59.3 39 13 −8 18
2 4066 40.7 −37 14 −30 13
LSTc−SC18 1 1 2763 100.0 −58 7 189 7
2 1 2763 100.0 50 9 −5 9
3 1 2724 98.6 −2 21 −42 11
2 39 1.4 40 7 25 8
4 1 1192 43.1 45 10 0 11
2 1069 38.7 19 13 −30 11
3 502 18.2 −33 18 −28 11
LSTc−NY18 1 1 1826 100.0 −46 10 194 7
2 1 1826 100.0 41 9 −7 11
3 1 1826 100.0 17 14 −43 12
4 1 1826 100.0 −31 13 −27 9
LSTc−AV18 1 1 2698 100.0 −51 8 192 7
2 1 2698 100.0 −24 14 −32 11
3 1 2698 100.0 24 13 34 11
4 1 2698 100.0 −28 12 −24 9
aThese angles for the ligand−receptor complexes were determined for those conformers that were extracted by PCA: g3, LSTc−SC18; g2, LSTc−
NY18; and g2, LSTc−AV18 (Figure 6 of the Supporting Information). The angles were determined by cluster analysis of the data illustrated in
Figure 13 of the Supporting Information, and the analysis used nonparametric density estimation36 to determine the members of each cluster. These
angles are average values for each ϕ and ψ cluster.
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were observed for the interaction between LSTa and AV18 or
NY18 that did not belong to Neu5Ac, weak signals were
observed for H3 and H4 of Gal-1, consistent with the partial
involvement of the Gal-1 residue in binding.
Given the conformational ﬂexibility of glycans, arising from
the numerous glycosidic torsion angles, the parameter θ has
been deﬁned as quantifying the form of the nonreducing end of
the receptors (Figure 1 and Materials and Methods). To
compare the conformational space sampled by the free and
bound ligand, tr-NOESY experiments were performed for LSTc
interacting with SC18 and NY18 (Figure 5 of the Supporting
Information). Notably, via comparison of the results from
bound and unbound LSTc, the NOE signals of the GlcNAc
methyl group are substantially diﬀerent. Whereas only the NOE
between the methyl group of GlcNAc and H5 of Neu5Ac was
observed for unbound LSTc, additional NOEs are observed in
the bound state with SC18, including signals associated with
protons H8 and H9. These ﬁndings agree with a decrease in the
distance between the GlcNAc (CH3 protons) and Neu5Ac (H5
and H8/H9 protons), which is probably correlated with a
reduction in the θ angle between the free and bound state. This
analysis indicates that, upon binding to SC18 and to a lesser
extent NY18, LSTc undergoes a conformational change,
reducing the θ angle and subsequently the level of conforma-
tional freedom of the Neu5Ac residue, particularly in the region
between atoms C6 and C9.
Molecular Dynamics Simulation of HA−Glycan Inter-
actions. The impact of glycan conformational diﬀerences and
points of glycan−HA interactions observed in the NMR
experiments was further investigated using MD simulations,
allowing a structural and dynamic comparison between the
various complexes (LSTc−SC18, −NY18, and −AV18 and
LSTa−AV18 and −NY18) to be made.
During the MD simulations, the conformational and dynamic
properties of the HA−glycan complexes progressively change,
especially those of the glycan conformation, with diﬀerences
arising in the complexes due to the amino acid mutations
within the RBS. It should be noted that the glycan starting
geometries are the same in the two sets of MD simulations,
with the LSTa and LSTc starting geometries taken from the
solution forms identiﬁed by Sassaki et al.28 The mobility
observed for the glycan in the HA RBS was monitored using
PCA, as described in Materials and Methods. Brieﬂy, the
analysis was performed on the distance matrix between the HA
and receptor; unlike the conventional PCA of protein MD
simulations, which uses the position of the protein backbone or
the dihedral angles of the protein, this focuses the analysis on
the interaction between the receptor and ligand. The temporal
changes in the conformational state of the LSTc−SC18
complex are reported in Figure 6C of the Supporting
Information; the conformer subset identiﬁed by cluster g3
represents the ﬁnal bound state of the complex, and a similar
representation for the LSTc−NY18 and LSTc−AV18 com-
plexes is shown in Figure 6 of the Supporting Information.
When LSTc is bound to any of the HAs, it appears to ﬁnd a
ﬁnal singular state; this is not the case for the LSTa−AV18 or
Table 2. Glycosidic Torsional Angles for LSTa, Free and Bound to NY18 and AV18a
linkage cluster size percentage ϕ (deg) SD of ϕ (deg) ψ (deg) SD of ψ (deg)
LSTa 1 1 8771 87.7 −62 10 −7 13
2 1191 11.9 −81 9 −55 9
3 21 0.2 230 6 47 8
4 17 0.2 209 12 −26 8
2 1 7317 73.2 41 13 −1 17
2 1917 19.2 −37 13 −20 13
3 766 7.7 61 12 57 10
3 1 5939 59.4 39 16 32 19
2 3290 32.9 20 13 −48 14
3 771 7.7 −28 11 −44 13
4 1 7861 78.6 40 13 −6 17
2 2139 21.4 −34 14 −30 12
LSTa−AV18 1 1 2426 100 206 15 −20 8
2 1 2426 100 51 9 19 15
3 1 1118 46.1 49 9 53 13
2 1308 53.9 25 12 42 12
4 1 2426 100 54 22 5 21
LSTa−NY18 1 1 3421 97.1 −64 11 −6 14
2 101 2.9 −73 10 −50 8
2 1 2674 75.9 −40 11 −16 14
2 484 13.7 45 11 1 12
3 364 10.3 23 13 −26 10
3 1 1939 55.1 22 15 −44 14
2 1234 35 −24 17 −42 14
3 349 9.9 47 14 14 19
4 1 1760 50 −36 14 −30 12
2 1762 50 35 15 −11 19
aThese angles for the ligand−receptor complexes were determined for those conformers that were extracted by PCA: g2−g5, LSTa−NY18; g1 and
g2, LSTa−AV18 (Figure 7 of the Supporting Information). Unlike when LSTc is bound to HA, multiple bound states were evident when LSTa was
bound to HA. These angles were determined by cluster analysis of the data illustrated in Figure 14 of the Supporting Information, and the analysis
used nonparametric density estimation36 to determine the members of each cluster. These angles are average values for each ϕ and ψ cluster.
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LSTa−NY18 complex, where the ﬁnal state of the latter MD
simulation is represented by at least four conformational
subsets (Figure 7C of the Supporting Information, clusters g2−
g5) and the former has two ﬁnal conformational subsets
(Figure 7F of the Supporting Information, clusters g1 and g2),
indicating a greater level of conformational freedom compared
to that for the case in which LSTc interacts with HA.
Inspection of the MD trajectory indicates that, in the case of
the LSTc−SC18 complex, all the monosaccharides of LSTc are
positioned to interact with the RBS (Figure 5A and Table 1 of
the Supporting Information). It is also apparent that both
hydrogen bonds and dispersive forces are important
components in the interaction of LSTc with SC18; speciﬁcally,
the methyl groups of GlcNAc show persistent contacts with
Leu194 and Asp190, while the methyl group of Neu5Ac
interacts with Gly134 and Trp153 (Figure 5A). Other
noteworthy interactions within the LSTc−SC18 complex are
between Gal-1 and Gln226, Lys222, and Asp225.
The presence of Gly instead of Asp at position 225, in going
from wild-type SC18 to NY18, removes the hydrogen bond
Figure 2. Main regions of the overlaid STD HSQC spectra of LSTc− and LSTa−receptor complexes. (A) STD spectra of LSTc−SC18 (purple) and
LSTc−NY18 (green) complexes overlaid upon the HSQC spectrum of LSTc. (B) STD spectra of LSTa−AV18 (orange) and LSTa−NY18 (blue)
complexes overlaid upon the HSQC spectrum of LSTa. The HSQC spectra and chemical shift assignments of LSTc and LSTa can be found in ref 28.
Individual ﬁgures, with each STD spectrum plotted over the relevant glycan HSQC spectrum, can be found in Figures 2 and 4 of the Supporting
Information.
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interaction between Gal-1 (OH3 and OH4) and the RBS
(speciﬁcally involving residues Gln226, Lys222, and Asp225),
thereby promoting a greater distance between Gal-1 and HA
(loop220) compared to that in SC18 (Figures 3B and 5B and
Table 1 of the Supporting Information). This result is clearly
supported by the NMR STD data (Figures 2 and 3), where
Gal-1, GlcNAc, Gal-2, and Glc resonances are absent from the
spectrum of the LSTc−NY18 complex or weaker than those in
the spectrum of the wild-type complex, corresponding to a
weaker interaction.
In the LSTc−AV18 complex, the further mutation of Asp190
to Glu introduces greater steric hindrance by preventing the
optimal interaction between the reducing end of LSTc and
helix190 of AV18, as can be seen by comparing the
corresponding distances in the MD simulation trajectories of
the LSTc−AV18 complex with those of the LSTc−SC18 and
LSTc−NY18 reference complexes (Figure 5 and Table 1 of the
Supporting Information). The consequence of this is that the
interaction between Gal-1 and the HA RBS is re-established
and Neu5Ac is drawn closer to the RBS, while the interaction
of GlcNAc is weaker than that in the LSTc−SC18 and LSTc−
NY18 complexes (speciﬁcally, Asp190 and Leu194 with
GlcNAc-CMe), with the whole residue moving away from
the RBS.
The analyses here reaﬃrm that it is interaction of Neu5Ac,
Gal-1, and GlcNAc with HA that is important for human
adaptation of inﬂuenza. These results provide a structural
description of the eﬀect caused by the single- and double-amino
acid mutations in the RBS of HA, which correlates with a
progressive weakening of the interaction between LSTc and
HA (SC18 > NY18 > AV18), a result also supported by NMR
STD experiments and the measured binding aﬃnities.
In the case of the LSTa−AV18 complex, the primary
contacts involve Neu5Ac of LSTa, with the carboxyl, acetyl, and
sialyl groups of Neu5Ac interacting with the HA RBS (Figure
4C and Figure 8 and Table 2 of the Supporting Information).
Importantly, contacts are also observed between AV18 and Gal-
1 in LSTa. This involves the interaction of O6-Gal-2 with
Glu190 and Pro186, which is aﬀorded by the presence of the
α(2→3) linkage in LSTa. PCA of the LSTa−AV18 MD
simulation trajectory also indicates the mobility of the reducing
end region of LSTa is greater than that of its nonreducing
terminus (Neu5Ac), which remains strongly attached to the
RBS on the MD simulation time scale (Figures 7 and Figure 8
and Table 2 of the Supporting Information). In the case of the
LSTa−NY18 complex, the mutation of Glu190 to Asp reduces
the extent of interaction between Gal-1 and the RBS, with only
the nonreducing end Neu5Ac residue interacting with the RBS.
A consequence of this is that the number of interactions
between the sialyl group of Neu5Ac and the RBS is decreased
and the interaction between Gln226 and the carboxyl group of
Neu5Ac is no longer observed (Figure 4D and Figure 9 and
Table 3 of the Supporting Information). This corresponds to a
weaker interaction between LSTa and NY18 than between
LSTa and AV18, in agreement with the NMR STD experiments
and biochemical assay. The LSTa−NY18 complex samples two
conformational states during the MD simulation, which diﬀer
on the basis of contacts between Neu5Ac and the HA RBS
(Figure 9 of the Supporting Information). The features of
binding of LSTa to AV18 and NY18 obtained from the MD
simulations are consistent with the corresponding NMR STD
signals, where data from both complexes indicate that Neu5Ac
is the main interacting residue with HA, while the methyl group
of GlcNAc is no longer a key point of interaction with either
NY18 or AV18.
We have compared the available X-ray crystallographic
structures with our MD and NMR structures (Figures 10 and
11 of the Supporting Information). The comparisons have been
limited to glycan−protein contact networks as the forms of the
glycans within the crystal structures are distorted, precluding
the determination of conformational angles.
Dynamics of LSTa and LSTc Conformations upon
Binding to HA. The θ angle parameter is a key conformational
Figure 3. N-Acetyl regions of the overlaid STD HSQC spectra of
LSTc− and LSTa−receptor complexes. (A) STD spectra of LSTc−
SC18 (purple) and LSTc−NY18 (green) complexes overlaid upon the
HSQC spectrum of LSTc. (B) STD spectra of LSTa−AV18 (orange)
and LSTa−NY18 (blue) complexes overlaid upon the HSQC
spectrum of LSTa. The HSQC spectra and chemical shift assignments
of LSTc and LSTa can be found in ref 28. Individual ﬁgures, with each
STD spectrum plotted over the relevant glycan HSQC spectrum, can
be found in Figures 2 and 4 of the Supporting Information.
Biochemistry Article
dx.doi.org/10.1021/bi500338r | Biochemistry 2014, 53, 4122−41354129
descriptor of the nonreducing end of the glycan receptor,
indicating the diﬀerent forms of the glycans. As shown
previously, the θ angle of unbound LSTc had a predominant
distribution at 86° and a smaller population located at 119°
(Figure 6A).28 Binding to SC18 substantially restricts the
conformational population of LSTc, as reﬂected by the narrow
distribution of the θ parameter, with a single distribution
centered at 82°. Binding to NY18 also restricts the conforma-
tional space sampled by LSTc, with a θ angle distribution being
located at approximately 90°. Interestingly, the small
population of θ angle values around 119° in the unbound
LSTc is absent in the bound state, consistent with an earlier
study in which it was postulated that long α(2→6) glycans
would predominantly adopt an umbrella-like topology (char-
acterized by θ < 100°) when bound to the RBS of human-
adapted HAs.18
This restriction of the θ angle when LSTc binds to SC18 and
NY18 is supported experimentally by the new NOE signal
appearing between GlcNAc and Neu5Ac H8/H9 in the tr-
NOESY spectra of the LSTc−SC18 complex and by the
stronger NOE signal between GlcNAc and Neu5Ac H5 in the
LSTc−NY18 complex (Figure 5 of the Supporting Informa-
tion). In contrast, low-aﬃnity interaction of LSTc with AV18
predominantly samples the cone-like topology as indicated by
Figure 4. (A) Structure of the LSTc−SC18 complex in the g3 cluster conformation subset (Figure 6C of the Supporting Information). (B)
Superposition of the RBSs of the LSTc−SC18 complex with that of the LSTc−NY18 complex (rmsd = 0.78 Å). The reported complex structures
belong to g3 and g2 conformations, respectively (Figure 6C,F of the Supporting Information). The carbon skeleton of LSTc bound to SC18 is
colored cyan, while LSTc interacting with NY18 is colored yellow. (C) Structure of the LSTa−AV18 complex corresponding to conformation subset
g2 of the PCA conformational characterization (Figure 7C of the Supporting Information). (D) Superimposed structures of the LSTa−AV18 and
LSTa−NY18 complexes (rmsd = 0.74 Å). The reported structure of the LSTa−NY18 complex corresponds to g2 and g1 conformation subsets as
obtained from PCA (Figure 7F of the Supporting Information). LSTa linked to AV18 is colored cyan, while LSTa interacting with NY18 is colored
yellow. The relevant amino acid residues of the shown HA active sites are underlined by a tube representation, with the name and numbering relative
to PDB entry 2WRG. The reported distances are in angstroms.
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the θ distribution around 113°, which is consistent with the
constraints imposed by avian-adapted HAs18 and is due to the
lack on interaction between GlcNAc and the RBS. These results
re-emphasize the ability of human receptors to sample a distinct
set of topologies (both umbrella-like and cone-like) in the RBS
of SC18, NY18, and AV18 HA.
In the unbound state, the θ angle of LSTa samples two
distinct populations centered around 118° and 154° (Figure
6B), both of which correspond to cone-like topologies (θ >
100°). The binding of LSTa to NY18 does not signiﬁcantly
alter the position of the θ angle distribution compared to that
of free glycan, distributions located at 117° and 158° in the
Figure 5. Contact network between LSTc and HA. If two vertices are linked, they are <6 Å apart; the thicknesses of the graph edges are inversely
proportional to the distance between the glycan atom (circular vertex) and the protein amino acid (square vertex) (the thicker the edge, the closer
the two are together). The square vertices that are white with a black boundary indicate that this amino acid has been mutated, for example, Asp190
→ Glu. The networks represent the average distances found in the ﬁnal, “bound”, conformer subsets identiﬁed by PCA (Figure 6 of the Supporting
Information): cluster g3, LSTc−SC18; cluster g2, LSTc−AV18; and cluster g2, LSTc−NY18. The distances illustrated here are listed in Table 1 of
the Supporting Information. In this ﬁgure, the distinct modes of the interaction between LSTc and HA (SC18, NY18, and AV18) can be observed.
When binding to its natural ligand, SC18, LSTc interacts with HA along its entire length. The single-point mutation forming NY18, Asp225→ Gly,
drastically alters the interaction between the nonreducing end of the receptor and HA, and the major interactions with Gal-1 are abolished (panel B
compared to panel A). The additional modiﬁcation forming AV18, Asp190→ Glu, allows Gal-1 to re-engage with HA, which leads to the interaction
between GlcNAc and amino acids 190 and Ser193 being lost (compare panel C to panels B and A).
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bound state, but does aﬀect strongly their relative populations,
with the population located at the smaller θ angle being the
largest. The binding of LSTa to AV18 HA imposes restrictions
on the θ angle, removing the population distributed around
117° (Figure 6B). Consistent with our previous studies, the
avian receptor LSTa adopts exclusively a cone-like topology
regardless of whether it is present in the unbound form or is
bound to NY18 or AV18 HA. For the sake of completeness, the
θ angle density plots for the entire MD trajectory (20−100 ns)
can be found in Figure 12 of the Supporting Information.
To complete our conformational studies, we also considered
the glycosidic torsion angles of the free and bound glycan
receptor sampled during the MD simulation; in the case of the
bound receptors, the conformer subset extracted by PCA is
considered (Tables 1 and 2).
First, consistent with the θ angle distributions described
above, comparison of the glycosidic torsional angles in the
unbound and various HA-bound glycans indicates there are
distinct structural constraints imposed by the RBS of SC18,
NY18, and AV18 HA on LSTa and LSTc. When LSTc binds to
SC18 and NY18, the distributions of states seen for ϕ1 and ψ1,
ϕ2 and ψ2, and ϕ3 and ψ3 are very similar; only by using density
cluster analysis is it possible to observe the diﬀerent central
locations of the states (Figure 13 and Table 1 of the Supporting
Information). Indicating the modiﬁcation of amino acid 190
(Asp → Gly) and the subsequent change in the interaction
between LSTc and HA, the loss of the interaction of Gal-1 with
Gln226, Asp225, and Lys222 does not have a strong eﬀect on
the glycosidic torsional angles, whereas binding of LSTc to
AV18 modiﬁes amino acids 190 and 225, which eradicates the
interaction between GlcNAc and Leu194, Asp190, and Ser193,
aﬀecting the positions of ϕ2 and ψ2 and those of ϕ3 and ψ3,
which are distinct from those observed in the LSTc−SC18 and
LSTc−NY18 complexes (Figure 13 and Table 1 of the
Supporting Information).
When LSTa binds to HA, the interactions with AV18 and
NY18 are very diﬀerent. The interaction between LSTa and
NY18 is solely through the nonreducing end Neu5Ac (Figure 9
of the Supporting Information), and this is evident in the
diversity of states observed for ϕ2 and ψ2, ϕ3 and ψ3, and ϕ4
and ψ4 (Figure 14 and Table 2 of the Supporting Information).
The opposite is seen for the LSTa−AV18 complex; even
though the glycan is dynamic with four conformational states
being extracted by PCA of the MD trajectory of the complexes
(Figure 7 of the Supporting Information), the glycosidic
torsional angle states observed in the glycan are restricted for all
four linkages.
■ DISCUSSION AND CONCLUSION
The NMR and MD simulation analyses described in this study
oﬀer new insights into the interaction between hemagglutinin
and its glycan receptors, providing a detailed description of the
contacts observed in the interactions between LSTc and LSTa
with human- and avian-adapted HA and the consequent change
in glycan conformation. The principal consequence of
modifying SC18 to form NY18, Asp225 → Gly, is that Gal-1
of LSTc can no longer interact with the HA RBS (Gln226,
Lys222, and amino acid 225), which allows Gal-1 to move away
from the protein surface, also aﬀecting the interaction between
the Neu5Ac residue of LSTc and the RBS. A further second
modiﬁcation forming the avian-adapted AV18, Asp190 → Glu,
permits Gal-1 of LSTc to re-engage with the HA RBS,
interacting with Gly225 and Lys222. While GlcNAc can no
longer interact with the RBS in the LSTc−AV18 complex, it is
this interaction that is a key decider for human adaption
(Figure 5). The interaction between LSTa and AV18, avian-
adapted HA, is principally via Neu5Ac and Gal-1 of the
receptor. The nonreducing end α(2→3) linkage between
Neu5Ac and Gal-1 in LSTa permits Glu190 and Pro186 to
interact with the sialyl group of Neu5Ac and O6-Gal-1 of LSTa.
The interaction between the glycan receptors and HA
imposes conformational constraints upon the glycan, which is
characterized in terms of the θ angle and the glycosidic
torsional angles. We also correlated this analysis with
biochemical HA−glycan binding speciﬁcity and aﬃnity to
ensure that this analysis is consistent with available crystal
structure information. Importantly, using the θ angle as a
parameter to characterize the overall shape of the glycan, our
study demonstrates key diﬀerences in the form of LSTa and
LSTc when they are free versus their bound states (LSTc−
SC18, −NY18, and −AV18 and LSTa−AV18 and −NY18),
which have not been possible to “capture” through X-ray crystal
structures.
Previously, we have noted that human receptors in their
unbound state sample a conformational space that resembles
both a cone-like topology (θ ≥ 110°) and an umbrella-like
topology (θ < 100°), whereas avian receptors exclusively
sample a cone-like topology.28 By analyzing HA−glycan
cocrystal structures, we postulated that glycans binding to
“avian-adapted” HA RBS (such as AV18) would impose
constraints on the human receptor (for example, LSTc) to
preferentially sample a cone-like topology, whereas glycans
binding to “human-adapted” HA (such as SC18) would
constrain the glycan to preferentially sample an umbrella-like
topology.18 On the basis of the NMR analyses and MD
simulations presented here, we demonstrate the former
hypothesis to be correct. The θ angle of LSTc (Figure 6A)
samples two distinct populations in the unbound state
corresponding to umbrella-like and cone-like topologies.
Upon binding to AV18 HA, LSTc predominantly samples a
cone-like topology (θ ∼ 110°); this is due to GlcNAc of LSTc
not being able to interact with the HA RBS. On the other hand,
binding to the RBS of SC18 or NY18 imposes constraints on
LSTc such that the glycan exclusively samples an umbrella-like
topology.
Furthermore, compared to free LSTc, the bound glycan has
restricted glycosidic torsional angles, with the torsional states
observed for the LSTc−SC18 and LSTc−NY18 complexes
being similar, whereas the mutation of Asp190 to Gly, seen in
AV18, which abolishes the interaction between GlcNAc of
LSTc and HA, produces unique glycosidic angles for ϕ2 and ψ2
and for ϕ3 and ψ3, which are distinct from those seen in the
LSTc−SC18 and LSTc−NY18 complexes. This restriction in
the glycosidic torsional angles is also observed in the LSTa−
AV18 complex, even though the receptor is dynamic in the
RBS, as indicated by the multiple states observed at the end of
the MD simulation (Figures 7 and 8 of the Supporting
Information), whereas in the LSTa−NY18 complex, where the
nonreducing end Neu5Ac is the sole point of interaction with
HA, linkages ϕ2 and ψ2, ϕ3 and ψ3, and ϕ4 and ψ4 all have
glycosidic torsional angles that are similar to those seen in the
free glycan (Figure 14 of the Supporting Information).
This stronger restriction correlates with a greater number of
LSTc−SC18 HA contacts, which can be observed in the NMR
STD measurements and higher measured binding aﬃnity
compared to those of the LSTc−NY18 HA complex. The
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constraints on the avian receptor, LSTa, are consistent with the
predominant contacts made by HA RBS with the Neu5Ac-
α(2→3)-Gal motif as measured by NMR STD signals, which
permit a higher degree of ﬂexibility to the sugars on the
reducing end of this terminal motif (as seen in the
conformational map of ϕ3 and ψ3 and of ϕ4 and ψ4 in Figure
14 of the Supporting Information).
The results presented here clearly indicate that even one or
two amino acid changes in the HA RBS impose diﬀerent
constraints on the conformation and topology of bound glycan
receptors, which in turn governs the biochemical binding
speciﬁcity and aﬃnity. On the basis of this evidence, it is
important to carefully assess the eﬀects of transferring amino
acid changes that lead to speciﬁc receptor binding properties
for a given HA to, and from, a completely diﬀerent strain or
subtype. As stated earlier, the receptor speciﬁcity of avian- and
human-adapted HAs has been broadly classiﬁed solely on the
basis of a preference for α(2→3)- and α(2→6)-linked sialic
acid. On the basis of the data presented here, we ﬁnd that the
amino acid composition of the RBS of various avian-adapted
HA subtypes would critically govern structural constraints
imposed on diverse and distinct sets of glycans expressed in
diﬀerent tissues, consistent with the ability of viruses from H5,
H7, and H9 subtypes to infect distinct tissue types. On the
other hand, human-adapted HAs share the characteristic
binding to glycans expressed in human upper respiratory
epithelia (particularly nonciliated goblet cells).20,21,37 This
characteristic binding can be explained on the basis of the
structural constraints imposed by SC18 and NY18 on LSTc,
which, in turn, is reﬂected by the θ parameter distribution.
Given that goblet cells secrete mucins, it is possible that the
characteristic binding of human-adapted HAs to these cell types
would increase their propensity for aerosol formation and
transmission.
Finally, the methods and framework presented in this study
to measure the restriction imposed by the RBS of diﬀerent HAs
on the conformational space and topology sampled by glycan
receptors can serve as a very useful tool for allowing more exact
surveillance of emerging inﬂuenza viruses such as H7N9 and
H5N1, to closely monitor their ability to bind to human
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